Navigation Links
Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents
Date:4/12/2011

EXTON, Pa., April 12, 2011 /PRNewswire/ -- Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that the company has received a grant of approximately $947,000 from the United States Department of Defense (DOD) to support the continued development of therapeutic monoclonal antibodies (mAbs) capable of neutralizing the toxic effects of botulinum neurotoxins (BOTN).  The development project is part of a U.S. defense initiative to protect citizens against toxic threats posed by biowarfare agents. In 2007, Morphotek was awarded $2.3 million in funding to support the initial development of these mAb therapies.

Morphotek has been developing mAbs with neutralizing activities against BOTN. These funds will further support the engineering of a monoclonal antibody-based therapy that can potentially protect against exposure to these toxins.

"The DOD funding will allow us to explore novel antibody formats capable of blocking the toxic effects of certain BOTN subtypes," said Luigi Grasso, Ph.D., Chief Scientific Officer at Morphotek.  "DOD's funding for this program demonstrates the importance of developing non-animal derived and safe biological therapies to treat potential exposure to different weaponized BOTN subtypes."

The funded program is in response to government efforts to develop therapies capable of protecting civilian and military personnel against exposure to pathogenic agents that can be deployed by rogue states or terrorists as bioweapons.  The program also is consistent with Morphotek's and Eisai's human health care (hhc) mission to give first thought to patients and their families and to increasing the benefits that health care provides by satisfying unmet medical needs.  

About MorphotekMorphotek®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
2. Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology
3. Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement
4. Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
5. Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
6. Morphotek(R), Inc. Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins
7. Morphotek®, Inc. Announces an Agreement with Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues
8. Morphotek®, Inc. Receives Beacon Award From CancerCare
9. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
10. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
11. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015 HUYA Bioscience International (HUYA) today announced ... Japan Society of HTLV-1, held this week at the ... of the Society is to promote research on HTLV-1 ... medical technology and research related to these fields to ... "HUYA is proud to support this prestigious conference," said ...
(Date:8/27/2015)... ... August 27, 2015 , ... Proove Biosciences, a ... the relationship of genetics and hypertension at the International Academy of Cardiology ... British Columbia, Canada. The event, which boasts an extensive overview of the latest ...
(Date:8/26/2015)... 2015  The Diabetes Research Institute (DRI), a ... Miller School of Medicine, announced today that the ... for the first time a novel transplant technique ... approved Phase I/II study builds upon decades of ... important first step toward the development of the ...
(Date:8/26/2015)... 2015 After litigating and negotiating patent ... to P2i United States patent RE43,651 ... the United States without any admission ... either party. As a result of the parties, settlement, the ... California dismissed the case without prejudice. ...
Breaking Biology Technology:HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4P2i Settles United States Litigation 2
... -- Spanning fewer than a thousand atoms, the electronic ... most efforts to characterize them. Now for the first time, ... devices by mapping them atom-by-atom. , ,In a study published ... John Booske, a UW-Madison professor of electrical and computer ...
... Madison, Wis. - Gov. Jim Doyle on Monday ... lauding Senate Majority Leader Bill Frist's recent decision to ... such research. , ,Doyle made his comments at the ... where he also praised Wisconsin's medical development scene. , ...
... provider of automated document delivery solutions headquartered in France, announced ... headquarters in Madison, in response to quickly growing use of ... mail processing facility extends the capabilities provided by the company's ... the U.S. , ,The Esker on Demand service, which also ...
Cached Biology Technology:Engineers chart semiconductors on the scale of atoms 2Engineers chart semiconductors on the scale of atoms 3Engineers chart semiconductors on the scale of atoms 4Doyle praises Frist's new stem cell research position 2Doyle praises Frist's new stem cell research position 3
(Date:8/6/2015)... Germany , August 6, 2015 /PRNewswire/ ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted display ... new solution, unprecedented quality and efficiency is brought to ... displays. For the first time, professionals and researchers can ...
(Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
(Date:8/5/2015)... Calif. , Aug. 5, 2015 The ... continuous growth in applications, penetration into newer sectors, and ... year. The global biosensors space has seen the entry ... the market so far. (Photo - ... & Sullivan, Analysis of the Global Biosensors Market ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
... 16, 2010) Researchers at Tufts University School of ... sequence that promotes increased numbers of specific microRNAs (miRNAs), ... The discovery helps researchers understand the links between miRNA ... findings are published in the August 13 issue of ...
... called microRNAs, control protein production primarily by causing the ... to be disabled by the cell, according to Whitehead ... microRNAs control protein production by causing the mRNAs to ... microRNAs impart by jamming the process that translates mRNAs ...
... Madrid, August 16, 2010.- Over 1.500 breast pathology experts will ... 16th World Congress of the Senologic International Society (SIS). This ... Senology and Breast Diseases (SESPM) will take place in the ... According to Dr. Carlos Vzquez, president of the SIS and ...
Cached Biology News:Newly identified RNA sequence is key in microRNA processing 2RNA snippets control protein production by disabling mRNAs 2RNA snippets control protein production by disabling mRNAs 31,500 worldwide experts debate the latest advances in breast pathologies' treatments in Valencia 2
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
Biotin anti-mouse CD48...
Biology Products: